GSK's Witty talks up U.K.'s R&D future; Exelixis gets priority review for cabo; AL biotech moves to MD;

Conversations on  Twitter :

 @FierceBiotech: Models shed light on cocaine-curbing enzymes. More | Follow @FierceBiotech

 @JohnCFierce: Wall Street oddsmakers betting heavily against Lilly's solanezumab. News | Follow @JohnCFierce

 @RyanMFierce: Illumina is poised to grab more bioinformatics dollars with its cloud computing product, eventual app store. Release | Follow @RyanMFierce

> GSK ($GSK) chief Andrew Witty is a big U.K. booster. And he's been talking up some new pluses for the biopharma industry, including a lower tax rate on IP-generated profits. Witty, though, also believes that the country needs more venture funds in order for the industry to compete with some up-and-coming European countries. Story

> The FDA has provided priority review status for Exelixis's ($EXEL) cabozantinib for thyroid cancer. Story

> University of Alabama spinout Vaxin has moved to Maryland, joining a cluster of vaccine developers near Washington, D.C. Story

Pharma News

 @FiercePharma: Endocyte poaches Novartis exec David Meek to be its chief commercial officer. Report | Follow @FiercePharma

> Shire CEO sees consumer-goods strategies in pharma's future. More

> Pay-for-delay deals could be upended by the Supreme Court. Article

Medical Device News

@FierceMedDev: Another day, another Covidien 510(k) clearance, this time for a new bedside monitoring system. Report | Follow @FierceMedDev

 @MarkHFierce: Four years of working with FDA pays off. Proteus gained clearance for a new ingestible sensor. Release | Follow @MarkHFierce

 @DamianFierce: A new pig-flesh-based implant could make certain knee surgeries more successful. More | Follow @DamianFierce

> Roper buys Dx firm Sunquest for $1.4B. News

> Devicemaker Kai Medical to merge with biotech Novogen. More

> Covidien rolls out updated patient monitoring system in U.S. Story

Biotech IT News

> AZ's R&D information chief eyes improved trial success. Story

> Models shed light on cocaine-curbing enzymes. More

> Illumina seeks cut of bioinformatics biz with cloud system. Article

> AstraZeneca taps Amazon-like service for outsourcing research. News

> Complete Genomics, Ingenuity combine forces to understand genomes. Report

CRO News

> Beta Pharma to manufacture Sunshine's targeted cancer drug. Story

> Quintiles inks deal to promote COPD drug in U.K. Article

> Analysts: CMO market will double by 2018. News

> 438 died in Indian clinical trials last year. Report

> Covance takes a $12.7M loss in Q2. News

And Finally… Investigators say that curcurmin, an ingredient in curry spice which acts as an anti-inflammatory compound, can help prevent diabetes. Story